Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentation at ESMO Congress 2023 - Arvinas (NASDAQ:ARVN), Pfizer (NYSE:PFE)
NEW HAVEN, Conn. and NEW YORK, Oct. 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN) and Pfizer Inc. (NYSE:PFE) today announced they will present updated Phase 1/2 data for vepdegestrant (ARV-471) at the 2023